Table 1.
Demographics and clinical characteristics of newly referred gynecologic oncology patients.
| Variable | Characteristics | Total | Pre-COVID-19 | COVID-19 | P value |
|---|---|---|---|---|---|
| N=884 | N=526 (60) | N=358 (40) | |||
| Age | Mean +/− SD | 56.5 (15.4) | 56.4 (15.7) | 56.6 (15.1) | 0.879 |
| Race | White | 717 (81.0) | 421 (79.9) | 296 (82.7) | 0.762 |
| Black | 143 (16.2) | 89 (16.9) | 54 (15.1) | ||
| Asian | 16 (1.8) | 10 (1.9) | 6 (1.7) | ||
| Other | 3 (0.3) | 2 (0.4) | 1 (0.3) | ||
| Unknown | 6 (0.7) | 4 (1.0) | 1 (0.3) | ||
| Ethnicity | Hispanic | 20 (2.3) | 15 (2.9) | 5 (1.4) | 0.251 |
| Non-Hispanic | 854 (96.5) | 504 (95.6) | 350 (97.8) | ||
| unknown | 11 (1.2) | 8 (1.5) | 3 (0.8) | ||
| Insurance | Private | 465 (52.5) | 290 (55.0) | 175 (48.9) | 0.400 |
| Medicare | 286 (32.3) | 164 (31.1) | 122 (34.1) | ||
| Medicaid | 106 (12.0) | 58 (11.0) | 48 (13.4) | ||
| Uninsured | 11 (1.2) | 5 (0.95) | 6 (1.7) | ||
| Other | 17 (1.9) | 10 (1.9) | 7 (2.0) | ||
| BMI | Mean +/− SD | 32.0 (10.0) | 31.6 (9.7) | 32.4 (10.4) | 0.268 |
| <30 | 426 (48.1) | 262 (49.7) | 164 (45.8) | 0.542 | |
| 30–39 | 287 (32.4) | 169 (32.1) | 118 (33.0) | ||
| 40–49 | 127 (14.4) | 73 (13.9) | 54 (15.1) | ||
| 50–59 | 27 (3.1) | 14 (2.7) | 13 (3.6) | ||
| 60–69 | 10 (1.1) | 6 (1.1) | 4 (1.1) | ||
| 70+ | 8 (0.9) | 3 (0.6) | 5 (1.4) | ||
| Comorbidities | Serious heart condition | 81 (9.2) | 54 (10.3) | 27 (7.5) | 0.192 |
| CKD | 68 (7.7) | 42 (8.0) | 26 (7.3) | 0.797 | |
| Diabetes | 156 (17.6) | 93 (17.7) | 63 (17.6) | 1.0 | |
| COPD | 46 (5.2) | 34 (6.5) | 12 (3.4) | 0.045 | |
| Sickle cell disease | 2 (0.2) | 0 | 2 (0.6) | 0.163 | |
| Immunocompromised | 6 (0.7) | 2 (0.4%) | 4 (1.1) | 0.229 | |
| Smoking status | Non-smoker | 734 (82.9) | 436 (82.7) | 298 (83.2) | 0.331 |
| Current smoker | 147 (16.6) | 87 (16.5) | 60 (16.8) | ||
| unknown | 4 (0.5) | 4 (0.8) | 0 | ||
| ECOG performance status | 0 | 415 (78.8) | 246 (80.4) | 169 (76.5) | 0.512 |
| 1 | 79 (15.0) | 45 (14.7) | 34 (15.4) | ||
| 2 | 25 (4.7) | 12 (3.9) | 13 (5.9) | ||
| 3 | 4 (0.8) | 1 (0.3) | 3 (1.4) | ||
| 4 | 4 (0.8) | 2 (0.7) | 2 (0.9) | ||
| Service location | Fellow Clinic | 100 (11.3) | 47 (8.9) | 53 (14.8) | 0.009 |
| Faculty Clinics | 785 (88.7) | 480 (91.1) | 305 (85.2) | ||
| Disease site | Uterus | 264 (29.8) | 155 (29.6) | 109 (30.5) | <0.001 |
| Ovary, fallopian tube, primary peritoneal | 96 (10.8) | 48 (9.1) | 48 (13.4) | ||
| Cervix | |||||
| Vulva | 108 (12.2) | 67 (12.7) | 41 (11.5) | ||
| Vagina | 47 (5.3) | 31 (5.9) | 16 (4.5) | ||
| Benign | 11 (1.2) | 5 (0.95) | 6 (1.7) | ||
| Other | 345 (39.0) | 210 (39.5) | 135 (36.9) | ||
| 14 (1.6) | 10 (2.3) | 4 (1.7) | |||
| FIGO stage | I | 233 (43.2) | 128 (40.3) | 105 (47.1) | <0.001 |
| II | 30 (5.6) | 9 (2.8) | 21 (9.4) | ||
| III | 79 (14.6) | 44 (13.9) | 35 (15.7) | ||
| IV | 49 (9.1) | 34 (10.7) | 15 (6.7) | ||
| Unstaged | 25 (4.6) | 13 (4.1) | 12 (5.4) | ||
| Pre-invasive | 124 (23.0) | 89 (28.1) | 35 (15.7) |
SD, standard deviation; BMI, body mass index; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; ECOG, Eastern Cooperative Oncology Group; FIGO, International Federation of Gynecologists and Obstetricians.